4D Molecular Therapeutics (FDMT)
NASDAQ:FDMT
US Market

4D Molecular Therapeutics (FDMT) Technical Analysis

78 Followers

Summary of all the Indicators

Summary
Buy
14Bullish
5Neutral
3Bearish
Oscillators
Buy
4Bullish
5Neutral
1Bearish
Moving Averages
Strong Buy
10Bullish
0Neutral
2Bearish
4D Molecular Therapeutics’s (FDMT) Moving Averages Convergence Divergence (MACD) indicator is 0.04, suggesting 4D Molecular Therapeutics is a Sell.
4D Molecular Therapeutics’s (FDMT) 20-Day exponential moving average is 17.95, while 4D Molecular Therapeutics’s (FDMT) share price is $18.08, making it a Buy.
4D Molecular Therapeutics’s (FDMT) 50-Day exponential moving average is 18.01, while 4D Molecular Therapeutics’s (FDMT) share price is $18.08, making it a Buy.

4D Molecular Therapeutics (FDMT) Pivot Points

Jun 02, 2023, 02:55 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
16.73
17.45
17.91
18.63
19.09
19.81
20.27
Fibonacci
17.45
17.90
18.18
18.63
19.08
19.36
19.81

4D Molecular Therapeutics (FDMT) Moving Averages

Jun 02, 2023, 02:55 PM
Period
Simple
Exponential
MA5
17.97Buy
18.09Sell
MA10
17.99Buy
18.01Buy
MA20
17.66Buy
17.95Buy
MA50
17.72Buy
18.01Buy
MA100
18.67Sell
17.85Buy
MA200
16.06Buy
15.35Buy
4D Molecular Therapeutics’s (FDMT) 10-Day exponential moving average is 18.01, while 4D Molecular Therapeutics’s (FDMT) share price is $18.08, making it a Buy.
4D Molecular Therapeutics’s (FDMT) 100-Day exponential moving average is 17.85, while 4D Molecular Therapeutics’s (FDMT) share price is $18.08, making it a Buy.
4D Molecular Therapeutics’s (FDMT) stock price is $18.08 and 4D Molecular Therapeutics’s (FDMT) 50-day simple moving average is 17.72, creating a Buy signal.
4D Molecular Therapeutics’s (FDMT) stock price is $18.08 and 4D Molecular Therapeutics’s (FDMT) 100-day simple moving average is 18.67, creating a Sell signal.
4D Molecular Therapeutics’s (FDMT) stock price is $18.08 and 4D Molecular Therapeutics’s (FDMT) 200-day simple moving average is 16.06, creating a Buy signal.

4D Molecular Therapeutics (FDMT) Technical Indicators

Jun 02, 2023, 02:55 PM
Name
Value
Action
RSI (14)
50.96
Neutral
STOCH (9,6)
54.33
Neutral
STOCHRSI (14)
60.63
Neutral
MACD (12,26)
0.04
Sell
ADX (14)
9.45
Buy
Williams %R
-57.92
Buy
CCI (14)
70.56
Neutral
ATR (14)
1.25
-
Ultimate Oscillator
41.81
Neutral
ROC
6.98
Buy
4D Molecular Therapeutics’s (FDMT) Relative Strength Index (RSI) is 50.96, creating a Neutral signal.
4D Molecular Therapeutics’s (FDMT) Trend Strength Indicator (ADX) is 9.45, creating a Buy signal.
4D Molecular Therapeutics’s (FDMT) Commodity Channel Index (CCI) is 70.56, creating a Neutral signal.
4D Molecular Therapeutics’s (FDMT) Price Rate of Change (ROC) is 6.98, creating a Buy signal.

FAQ

Is FDMT a Buy, Hold, or Sell?
Based on FDMT’s technical indicators, FDMT is a Buy.
    What is FDMT’s RSI (14)?
    FDMT’s RSI (14) is 50.96, which suggests FDMT is a Neutral.
      What is FDMT’s MACD?
      FDMT’s MACD is 0.04, which suggests FDMT is a Sell.
        What is FDMT’s 5-day moving average?
        FDMT’s 5-day moving average is 17.97, which suggests FDMT is a Buy.
          What is FDMT’s 20-day moving average?
          FDMT 20-day moving average is 17.66, which suggests FDMT is a Buy.
            What is FDMT’s 50-day moving average?
            FDMT’s 50-day moving average is 17.72, which suggests FDMT is a Buy.
              What is FDMT’s 200-day moving average?
              FDMT’s 200-day moving average is 16.06, which suggests FDMT is a Buy.
                What is FDMT’s Williams % R (14)?
                FDMT’s Williams % R (14) is -57.92, which suggests FDMT is a Buy.
                  What is FDMT’s CCI (14)?
                  FDMT’s CCI (14) is 70.56, which suggests FDMT is a Neutral.

                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis